Differences according to phenotype (e.g., PR3- vs. MPO-ANCA+ and GPA vs. MPA) were observed regardless of whether ANCA type or clinicopathologic condition was used to group patients, but the differences were more striking when PR3- and MPO-ANCA patients were compared to one another. This evidence concerns the gene PRTN3 and granulomatosis with polyangiitis.